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Gentle probing against the cervix via the vagina (vaginocervical stimulation, VCS) increases
tail ﬂick latency (TFL) to radiant heat; greater force abolishes the tail ﬂick response and other
withdrawal responses.This effect occurs in spinal cord-transected rats and in intact rats. On
the basis of our earlier ﬁnding that VCS releases vasoactive intestinal peptide (VIP) into the
spinal cord, and others’ reports of neurotrophic effects ofVIP in vitro, we hypothesized that
repeated VCS would stimulate sprouting and sensorimotor function of terminals of genital
nerve primary afferents in the sacral spinal cord. To test this hypothesis, in the present
study, we denervated the genital tract only unilaterally, which signiﬁcantly reduced the
TFL-elevating effect of VCS. Then we applied repeated daily VCS for 1 week and compared
the subsequent effectiveness of acute VCS in elevating TFL. The rats that received the
repeated dailyVCS showed a signiﬁcantly greater elevation inTFL in response to acuteVCS
than control rats that did not receive the repeated stimulation. Then, to test whether daily
repeated VCS stimulates sprouting of genital primary afferents in such unilaterally genital
tract-denervated rats, we transected the contralateral remaining intact pelvic nerve, applied
horseradish peroxidase (HRP) to its proximal cut end for 1–2 h, and 2–3 days later counted
HRP particles in its terminal zone (L6–S1) in the spinal cord. There were signiﬁcantly more
HRP particles in the rats that received the daily repeated VCS than in the control rats.
In the context of these ﬁndings, we conclude that VCS in rats can produce a functional
sensorimotor recovery via a neurotrophic effect on compromised primary afferents in the
spinal cord.
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INTRODUCTION
Vaginocervical stimulation (VCS) in rats acts at the spinal cord
to block withdrawal reﬂexes to noxious stimulation. Hind leg and
tail withdrawal reﬂexes, which persisted after surgical removal of
a segment of the spinal cord at the mid-thoracic level, were still
completely blocked byVCS (Komisaruk andLarsson,1971). Apos-
sible mechanism for this effect is that foot-shock-induced release
of substance P into spinal cord superfusate is inhibited by concur-
rent VCS (Steinman et al., 1994). The pelvic nerves, which provide
sensory innervation of the vagina and cervix (Komisaruk et al.,
1972; Peters et al., 1987; Berkley et al., 1990, 1993) are the main
mediator of this VCS-induced reﬂex inhibition, for transection of
the pelvic nerves almost completely abolishes the ability of VCS
to blockwithdrawal reﬂexes (Cunningham et al., 1991). Vasoactive
intestinal peptide (VIP) is a possiblemediator of this effect of VCS,
for pelvic nerve contains VIP (Basbaum and Glazer, 1983), VCS
releases VIP into spinal cord superfusates (Komisaruk et al., 1989
), andVIP and certain of its fragments administered directly to the
spinal cord, intrathecally, mimic the analgesia-producing effects
of VCS (Komisaruk and Jordan, 1995). And in a different con-
text,VIP exerts neurotrophic effects (Brenneman and Eiden, 1986;
Gozes et al., 1991; Gressens et al., 1993; Brenneman et al., 1999).
These ﬁndings combined led us to hypothesize that VCS could
promote recovery of spinal cord-mediated behavioral function. To
test this hypothesis, we ﬁrst reduced the inhibitory effect of VCS
on the tail ﬂick latency (TFL) to radiant heat test by transecting
the pelvic nerve unilaterally. In order to maximize the unilateral
genital neurectomy effect, we also ipsilaterally transected the other
genital sensory nerves, i.e., the pudendal and hypogastric (Komis-
aruk et al., 1972; Peters et al., 1987; Berkley et al., 1990, 1993).
Thenwe applied repeatedVCS three times daily for 1week.We rea-
soned that the daily repeatedVCSwould stimulate sprouting of the
remaining intact pelvic nerve terminals, and thereby increase the
effectiveness of theVCS. Thus, in the present study, we ascertained
whether: (a) unilateral genital neurectomy would reduce the mag-
nitude of VCS-induced inhibition of the TFL, (b) daily repeated
VCS would overcome this attenuation, and (c) the daily repeated
VCS would induce sprouting of the remaining intact pelvic nerve
terminals.
MATERIALS AND METHODS
EXPERIMENT 1. DOES DAILY REPEATED VCS IN GENITAL
UNILATERAL-NEURECTOMIZED RATS INCREASE ITS
INHIBITORY EFFECT ON TFL?
Subjects
Sprague Dawley female rats at least 90 days of age and weighing
300–400 g, were purchased from Charles River Breeding Labo-
ratories. All animals were maintained on a reversed-light cycle
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(lights on 7:00 p.m. to 10:00 a.m.) with food and water ad libitum.
Rats were housed two per cage in tubs with absorbent material
ﬂooring. All rats were ovariectomized at least 1 month prior to
nerve transections to eliminate variability in response to VCS due
to ﬂuctuating levels of ovarian hormones (Crowley et al., 1976).
Groups
Animalswere randomly assigned to the following groups: C: sham-
operated controls, n = 10; GenX: unilateral pelvic-hypogastric-
pudendal neurectomy, n = 11; GenX + VCS: unilateral pelvic-
hypogastric-pudendal neurectomy receiving three times daily
VCS, n = 11; C + VCS: intact controls receiving three times daily
VCS, n = 12.
Surgery
All experimental procedures used in the present study received
approval from the Rutgers University Institutional Animal Care
and Use Committee. Nerve transections: rats were anesthetized
with a solution of 0.5 ml Rompun/10 ml ketamine; dose:
0.07 ml/100 g body weight. A ventral abdominal incision, approx-
imately 6 cm length, exposed the abdominal–pelvic region and
facilitated the identiﬁcation of the genitospinal nerves.
Unilateral hypogastric neurectomy. We identiﬁed the left ureter
by its vigorous peristaltic activity, then visualized the left hypogas-
tric nerve between the colon and the ureter as it courses parallel to
the ureter, and removed a 4 mm segment of the nerve.
Unilateral pelvic neurectomy. The bifurcation of the vena cava
into the common iliac veins was identiﬁed, the left common iliac
vein was followed caudad, approximately 1 cm, to the origin of the
left internal iliac vein. Approximately 5 mm dorsal to the origin of
the left internal iliac vein, perpendicular to its axis, we identiﬁed
the left pelvic nerve as it courses rostrocaudad, lying across the
vein, and removed a 4 mm segment.
Unilateral pudendal neurectomy. The left pudendal nerve was
located dorsal and parallel to the left pelvic nerve as it, also,
lies across the internal iliac vein. The pudendal nerve is well-
myelinated and glistens, relative to the pelvic nerve. A 4 mm
segment was removed.
Shamneurectomy. Thehypogastric, pelvic, andpudendal nerves
were located unilaterally, and then eachnervewas gently liftedwith
a microsurgical hook and returned to its original site.
Behavioral testing
Baseline TFL responses to VCS were obtained 1 week prior to
neurectomy or control procedures. Each rat was placed in a
hemi-cylindrical Plexiglas restrainer for approximately 5 min
prior to testing. TFL responses before and during VCS (100
and 300 g force) were established prior to neurectomy or sham
surgery.
TFL test. This measures the latency (in s) to ﬂick the tail away
from a focused regulated radiant heat source. The radiant heat
source (IITC Inc., Model 33) was located 8 cm above and 4 cm
proximal to the tip of the tail. The temperature of the heat lamp
of the tail ﬂick apparatus was adjusted to elicit a group mean
approximate TFL of 3 s. The TFL reading displayed automatically
when the rat withdrew the tip of its tail away from the radiant heat
source, breaking a photocell circuit. To prevent tissue damage,
the heat source was stopped at 9 s if the rat did not withdraw its
tail. Each test consisted of three trials 15 s apart. The score for
each test was calculated as the mean latency of three successive
trials.
Acute VCS. VCS (100 and 300 g force) was applied to the cervix
using a calibrated “Force Dial Hand Held Dynamometer” (Model
FD 500, Wagner Instruments, Greenwich, CT, USA). The tip
of the metal plunger of the force-calibrated dynamometer was
shaped with a dental sanding disk in order to match the tip
of a 1 cc plastic syringe plunger. To provide cushioning during
VCS, we placed the rubber tip of a 1 ml plastic syringe onto this
modiﬁed tip.
Daily repeated VCS began 18 h after unilateral neurectomies
and continued for 1 week. VCS (100 g force, 10 s on, 10 s
off × 5 min) was applied three times daily, 2 h apart. The effect of
acute VCS on TFL (100 and 300 g force) was ascertained 1 week
after the daily VCS treatment ended, using a blind procedure.
Statistical analysis
The data are expressed as mean ± SEM. Comparison among
groups was made using repeated measures, Two-way analysis of
variance (ANOVA), and subsequent Fisher’s protected t-tests.
EXPERIMENT 2. DOES DAILY REPEATED VCS INDUCE SPROUTING
IN GENITAL PRIMARY AFFERENT NERVE TERMINALS?
Subjects
Eight Sprague Dawley female rats were purchased from Charles
River Breeding Laboratories, at least 90 days of age and weighing
250–400 g at the time of surgery. They were ovariectomized at
least 2 weeks before surgery and maintained on a reversed-light
cycle (lights on 7:00 p.m. to 10:00 a.m.) with food and water
ad libitum.
Groups
Animals were randomly assigned to the following groups: Control
group: the genitospinal nerves (hypogastric, pelvic, and puden-
dal nerves) were transected unilaterally (right side) as described
above, n = 5; VCS-treated group: the genitospinal nerves were
transected unilaterally (right side). Then, beginning 18 h after
unilateral neurectomies VCS (100 g force) was applied for 5 min
(10 s on/10 s off), 2 h apart, three times a day for 1 week, n = 3.
Two weeks post-surgery, in both the control and VCS-treated
groups, the remaining intact contralateral nerve (pelvic nerve)
was transected and the proximal end was dipped into horseradish
peroxidase (HRP) (see details of method below). Two to three days
after the nerve dip, the animals were sacriﬁced and the density of
HRP particles in the terminal ﬁeld of the nerve in the spinal cord
was determined.
Pelvic nerve transection and pelvic nerve dip
Fourteen days post-lesion, the rats were anesthetized as above and
the left pelvic nerve was exposed at the pelvic ganglion level and
transected with microscissors. Approximately 5 μl HRP dissolved
in saline (50 U/μl) was used to ﬁll a small cup made by cutting
PE-10 tubing to ﬁt the nerve and closing one end with petroleum
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jelly. The cut end of the proximal pelvic nerve was placed into
the cup and exposed to the tracer for 1–2 h. At the end of this
period, the cup was gently removed from the pelvic nerve end and
the incision sutured. The animals were then allowed to survive for
2–3 days.
Perfusion and tissue preparation
Two to three days after the nerve dip, the animals were deeply
anesthetized as described above, and perfused, via the ascending
aorta, with physiological saline at room temperature (50 ml/rat),
followed by a solution of 1% paraformaldehyde and 1.25% glu-
taraldehyde in 0.1 M phosphate buffer at room temperature
(500 ml/rat). After perfusion, the L6–S1 spinal cord segments
were identiﬁed and removed, placed in a sucrose-buffer solu-
tion at 4◦C for 12–24 h and cut into 30 μm sections using a
cryostat.
Horseradish peroxidase histochemistry
The mounted sections were processed for HRP histochemistry
by using tetramethylbenzidine as the chromogen and stabilized
with sodium nitroprusside according to the method of Mesu-
lam and Brushart (1979). The sections were then air-dried
overnight, cleared in hemoD, coverslippedwith Permountmount-
ing medium and examined under a Nikon light microscope using
darkﬁeld illumination. In all cases, the investigator making the
histological observations was blind as to the treatments that cor-
responded to the slides. All sections L6–S1 were examined for
the presence of HRP particles. HRP particles (reaction prod-
uct granules) were identiﬁed and counted manually using the
software program, “Neurolucida,” under darkﬁeld illumination.
Spinal cord regions were identiﬁed and delineated according to
Rexed’s laminae, and the area of each region determined with the
software program,“Neuroexplora.”The selection of these sections
was based on the presence of maximal HRP label intensity at the
sacral parasympathetic nucleus (SPN) as observed under darkﬁeld
microscopy. The average of three sections (L6–S1) per animal was
used to measure the density of HRP particles for each spinal cord
region. HRP particle density was calculated by counting the total
number of HRP reaction product granules and then dividing this
value by the area of the corresponding spinal cord region. The
images of the selected sections were analyzed using a Kodalith
threshold that was adjusted for each image after manually identi-
fyingHRP particles and excluding background levels and artifacts.
The average particle size was set at (0.01–5 μm2) and the average
size of 3 μm was used to separate and thereby identify individual
particles.
Statistical analysis
The data are expressed as the medians and interquartile ranges.
The groups were compared using Mann-Whitney U-tests.
RESULTS
EXPERIMENT 1. EVIDENCE THAT DAILY REPEATED VCS INCREASES THE
INHIBITORY EFFECT OF VCS ON TAIL FLICK
As summarized in Figure 1, all groups showed equivalent baseline
(pre-VCS; “0 g force”) TFLs. As anticipated, the TFL in response
to acute VCS (100 or 300 g force) was signiﬁcantly lower in the
unilateral genital neurectomy (GenX) group than in the intact
FIGURE 1 | Unilateral genital neurectomy significantly reduced
the ability ofVCS to elevateTFL. Daily repeated VCS in unilateral
genital-neurectomized rats increased the ability of acute VCS to elevate TFL
compared to their controls that did not receive daily repeated VCS (see text
for details). C, intact controls; GenX, unilateral genital neurectomy;
GenX + VCS, unilateral genital neurectomy plus daily repeated VCS;
C + VCS, intact rats receiving daily repeated VCS. *p < 0.01, +p < 0.05;
signiﬁcantly greater, by Fisher’s protected t -test, than within-group baseline
(0 g force of acute VCS). Bars that do not share the same letters are
signiﬁcantly different from each other, within- or between-groups (ANOVA
plus subsequent paired comparisons; p < 0.05)
control (C) group (p < 0.01, Fisher’s protected t-tests). Thus, the
unilateral neurectomy signiﬁcantly reduced the ability of VCS to
inhibit the tail ﬂick response. The TFL elevation to 300 g (although
not 100 g) VCS was signiﬁcantly higher in the unilateral neurec-
tomy + daily VCS group (GenX + VCS) than in the unilateral
neurectomy group that did not receive daily VCS (GenX). How-
ever, in the intact group, daily repeated VCS (C + VCS) did not
increase the ability of acute VCS to increase TFL any more than in
the intact group that did not receive daily repeatedVCS (C). Thus,
the higher VCS force revealed the effect of daily repeated VCS to
increase the ability of VCS to inhibit the tail ﬂick response in the
genital-neurectomized rats.
EXPERIMENT 2. EFFECT OF UNILATERAL NERVE TRANSECTION
AND DAILY REPEATED VCS ON HRP LABELING OF PELVIC
NERVE TERMINALS
HRP reaction product was located in the L6–S1 segments of the
spinal cord. The primary afferent ﬁbers enter this region through
Lissauer’s tract, diverging into a medial and a lateral band sur-
rounding the superﬁcial border of the dorsal horn. The collaterals
of some primary afferents that course along the lateral band
approach, and form connections with, SPNs and dendrites. Other
collaterals course among SPNs and dendrites to form a termi-
nal ﬁeld in the upper dorsal gray commissure with fewer ﬁbers
crossing to the contralateral side of the spinal cord. The pri-
mary afferent collaterals emerging from the medial band form
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FIGURE 2 | In rats that received daily repeatedVCS, there was
increased HRP labeling in the terminal fields of the pelvic nerve at
L6–S1 compared to rats that did not receive suchVCS, suggesting that
the daily repeatedVCS induced sprouting (details in the text).The y -axes
depict the number of HRP particles/1×104 μm2. XR, HRP counts on the right
side of the spinal cord; XRVCS, HRP counts on the right side of the spinal
cord after 1 week of daily repeated VCS; L, HRP counts on the left side of
the spinal cord; LVCS, HRP counts on the left side of the spinal cord after
1 week of daily repeated VCS. In general, daily repeated VCS increased
the number of HRP granules compared to rats that did not receive such
VCS. **p < 0.02 (Mann–Whitney U -tests), *p < 0.05 (Mann–Whitney
U -tests). Notes: In all four groups, the right pelvic nerve was ﬁrst
transected 2 weeks earlier. Scales for HRP granule counts are different
in the different groups.
a terminal ﬁeld in the upper dorsal gray commissure. Primary
afferent collaterals/terminals are also located in Laminae I, II, and
X (Figure 3).
EVIDENCE THAT DAILY REPEATED VCS INCREASES HRP LABELING
The purpose of transecting the genitospinal nerves unilaterally
(on the right side) was to clear a ﬁeld for the ipsilateral and con-
tralateral terminals of the remaining contralateral pelvic nerve to
potentially proliferate. As can be seen in Figure 2, in the non-
VCS group (XR and L), there was minimal HRP labeling in either
the ipsilateral or the contralateral side of the spinal cord in the
regions speciﬁed. By contrast, in the VCS group (XRVCS and
LVCS), there was signiﬁcantly more labeling than in the non-VCS
group in six of the eight ipsilateral (i.e., left side) intact regions.
And in six of the eight neurectomized (i.e., right side) regions,
there was signiﬁcantly more labeling in the XRVCS group than in
the non-VCS (XR) group. Thus, whereas relatively minimal HRP
labeling occurred in the terminals in the absence of VCS, there
was a marked increase in HRP labeling on both the ipsilateral and
the contralateral sides in the group that received daily repeated
VCS. Table 1 summarizes the median number of HRP particles
observed in each region of the spinal cord.
DISCUSSION
In the present study, unilateral denervation of the reproductive
tract signiﬁcantly reduced the magnitude of VCS-induced inhibi-
tionof the tail ﬂick response to radiant heat. Daily repeatedVCS for
1 week then signiﬁcantly increased (restored) its analgesic effec-
tiveness in these unilateral genital-denervated rats, whereas in the
intact control rats, the same type of VCS did not increase further
the analgesia magnitude.We tested a possible morphological basis
for this effect by ﬁrst transecting the pelvic nerve on the right
side in order to vacate its terminal projection ﬁeld. Subsequently,
we applied HRP to the acutely cut proximal end of the remain-
ing intact pelvic nerve on the left side, and then counted HRP
reaction product in the pelvic nerve terminal projection zone at
spinal cord level L6–S1 (Nadelhaft and Booth, 1984). The present
ﬁndings provide support for the interpretation that daily repeated
VCS increased the terminal proliferation, on the basis that the daily
repeated VCS signiﬁcantly and markedly increased the counts of
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FIGURE 3 | Darkfield illumination photomicrograph (Neurolucida) of
transverse 30-μm sections of the sacral 1 (S1) segment of the spinal
cord.The right side of the ﬁgures is the left side of the spinal cord. (a) HRP
labeling in a rat that received daily repeated VCS. Brightened image to
emphasize appearance and location of HRP particles (white dots). (b) Same
section as above showing how HRP counting was made. The white marker
dots indicate the locations of HRP particles. Different types of marker dots
were used to differentiate the selected regions of the spinal cord. (c) HRP
labeling in a control rat that did not receive daily repeated VCS. Calibration
bar = 200 μ.
HRP reaction product in the pelvic nerve terminal ﬁeld in six of
the eight ipsilateral terminal ﬁelds measured, as well as in six of
the eight contralateral terminal ﬁelds measured (The pelvic nerve
distributes its terminals ipsi- and contra-laterally; Basbaum and
Glazer, 1983; Chung et al., 1993).
Table 1 | Regional distribution of median number of HRP
particles/1 × 104 μm2.
Spinal cord region XR XRVCS L LVCS
Lissauer’s tract 0 1.88 0 61.33
Medical collateral band 0 4.47 0 37.76
Dorsal gray commissure 1.15 21.38 0.90 30.88
Dorsal horn (central) 0.70 5.19 3.39 7.73
Lateral collateral band 0 0 0 138.09
Laminae I and II 1.20 4.33 0.90 8.55
Lamina X 0.86 6.64 1.04 7.43
Dorsal horn (total) 4.04 44.01 5.12 273.47
This is a numerical summary of the data shown in Figure 2. In the control group
(n = 5), the right genitospinal (hypogastric, pelvic, pudendal) nerves were tran-
sected (XR) 2 weeks before HRP administration to the intact contralateral pelvic
nerve [left side of the spinal cord (L)]. In the experimental group (n = 3) rats were
treated with a daily regimen of VCS following unilateral right side genitospinal
nerve transection (XRVCS). Following daily VCS treatment HRP was administered
to the intact contralateral pelvic nerve (LVCS). HRP counts were done in both
sides of the spinal cord (see text for details).
The validity of the quantitativeHRPmethodused in the present
study is supportedbyourﬁndingof a distributionof primary affer-
ent ﬁber terminals consistent with the distribution described by
others (Nadelhaft and Booth, 1984). According to those authors,
pelvic nerve primary afferent ﬁbers enter Lissauer’s Tract in the
spinal cord in the same segments (L6–S2) as those in which the
preganglionic neurons are located that enter the pelvic nerve effer-
ents. This supports our criterion for selecting, for quantitative
HRP analysis, sections with SPN neurons showing maximal HRP
label, since these sections also contain primary afferent ﬁbers and
terminals of the pelvic nerve.
We speculate that themarkedquantitative increase inHRPreac-
tionproduct in the pelvic nerve terminal ﬁelds in the daily repeated
VCS group represents VCS-induced proliferation, i.e., sprouting,
of pelvic nerve primary afferent terminals in the spinal cord,
thereby mediating the ability of repeated daily VCS to increase
its tail ﬂick response-inhibiting potency.
A mechanism for this effect may be the release of neurotrophic
substances into the dorsal horn of the spinal cord, inducing
sprouting of intact pelvic nerve ﬁbers into the denervated region.
Sprouting occurs spontaneously within 2 weeks of trauma (Woolf
et al., 1995); the present ﬁndings suggest that daily repeated VCS
can markedly intensify this process. Several other mechanisms
could play a role in functional recovery of the CNS in response
to injury, e.g., a rearrangement of spared neuronal circuits, an
upregulation of neuropeptides with neurotrophic abilities (Muir
and Steeves, 1997), and/or an acceleration of transport of neu-
rotrophic substances to the terminal ﬁelds, perhaps represented
by HRP accelerated transport of HRP particles. VCS, which acti-
vates the pelvic nerve, releasesVIP into the spinal cord (Komisaruk
et al., 1989). Evidence that VIP is a neurotrophic factor is that it
induces neurite growth in vitro and protects neurons from cell
death (Brenneman and Eiden, 1986; Pincus et al., 1990; White
and Mansﬁeld, 1996). VIP increases neuronal survival indirectly,
via the release of several neurotrophic substances from glial cells
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(Brenneman et al., 1987, 1990). VIP exerts neurotrophic effects
on developing neurons in the CNS (Brenneman and Eiden, 1986);
dissociated cell cultures and whole embryo cultures showed a
marked increase in growth markers in response to VIP treatment
(Gressens et al., 1993); andVIP increases the survival of electrically
blocked spinal neurons (Brenneman and Eiden, 1986; Brenneman
et al., 1999). Also, blocking the action of VIP with neutralizing
VIP antisera or withVIP receptor antagonists resulted in neuronal
cell death for a subpopulation of CNS neurons in spinal cord,
hippocampus, and cerebral cortex (Brenneman and Eiden, 1986;
Gozes et al., 1991).
These ﬁndings led us to speculate that VCS, by releasing VIP
into the spinal cord, could promote the recovery of spinal cord-
mediated behavioral function for which evidence is presented in
the present study.
Because the TFL test measures a motor response, from this
test one cannot distinguish whether the inhibitory effect of
VCS on the tail ﬂick response is on the motor response only,
nociception only, or both. However, there is substantial evi-
dence that VCS does at least produce analgesia. That is, in rats
VCS inhibits nociceptive responses in thalamic sensory neurons
(Komisaruk and Wallman, 1977), and in women vaginal/cervical
self-stimulation produces a marked elevation in pain thresholds
(Komisaruk and Whipple, 1984; Whipple and Komisaruk, 1985).
Those effects are analgesic, rather than anesthetic, because in both
cases, responses to innocuous tactile stimulation were not affected
by the VCS.
The present study focuses on the proliferation of primary affer-
ent pelvic nerve terminals in the spinal cord in response to daily
repeated VCS and the resulting increase in the analgesic effect
of VCS. While this process involves an active inhibitory process
within the spinal cord, there is evidence that a parallel supraspinal
process is also activated by VCS. That is, in women with complete
spinal cord injury at T10 or above, we previously showed that
vaginal or cervical self-stimulation produces analgesia, evidenced
by signiﬁcant increases in pain thresholds to calibrated compres-
sive force applied to the ﬁngers (Komisaruk et al., 1997). Evidence
that this analgesia is mediated by the vagus nerves is that by using
functional MRI in these women, we found that the vaginal or
cervical self-stimulation activated the terminal projection zone of
the vagus nerves in the medulla oblongata, i.e., the nucleus of
the solitary tract (Komisaruk et al., 2004). Thus, the vagus nerves
(cranial nerve 10) provide a previously unrecognized genital sen-
sory pathway directly to the brain, bypassing the spinal cord. And
stimulation of this nerve via the vagina or cervix can produce
analgesia.
On the basis of the present ﬁndings that daily repeated VCS
can increase the analgesic action of VCS by proliferating pelvic
nerve terminals in the spinal cord, it is tempting to speculate
that the same stimulus could stimulate the proliferation of vagus
nerve terminals above complete spinal cord injury at any level, for
the terminal ﬁelds of genital afferents ascending to the brain via
the spinal cord would also be vacated by the de-afferentation. An
intriguing possibility is whether, via the vagus nerve afferents, in
womenwith“complete”spinal cord injury at or above T10, vaginal
or cervical self-stimulation could attenuate pain that is perceived
above – and, via the vagus nerve pathway even below – the level of
complete spinal cord injury, and whether repeated VCS in women
could augment the attenuation of such pain.
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